Centinel Spine received FDA 510(k) clearance for its FLX Platform of Integrated Interbody and non-integrated interbody fusion devices.
Here are four things to know:
1. The FLX Platform consists of 3D-printed, all-titanium devices with a combination of solid and porous radiolucent sections intended to reduce mechanical stiffness and improve visibility relative to solid titanium implants.
2. The devices feature the proprietary Fuse-Thru trabecular scaffold, which is engineered to allow for bony in-growth and on-growth throughout the implant.
3. Stalif FLX Integrated Interbody devices are indicated for use at one or two contiguous levels with both autograft and/or allogenic bone graft.
4. Centinel Spine is the largest privately-held spine company and is focused on anterior column reconstruction.
More articles on surface technology:
Camber Spine receives FDA clearance for titanium ALIF device: 3 insights
Oxford Performance Materials teams up with JSR Corp. to advance PEKK line in Asia: 4 insights
K2M receives FDA clearance for patient-specific BACS platform: 5 things to know